Fall 2021 Virtual EXPO CENTRAL


Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development, and commercialization of proprietary therapeutics.

For additional information on Incyte, please visit Incyte.com and follow @Incyte on Twitter. For more information on OPZELURA™ (ruxolitinib) cream 1.5%, visit OpzeluraHCP.com.

Please see link below for Opzelura cream 1.5% Full Prescribing Information including the Boxed Warning, for more information please visit OpzeluraHCP.com